1. Academic Validation
  2. Indolocarbazoles: potent, selective inhibitors of human cytomegalovirus replication

Indolocarbazoles: potent, selective inhibitors of human cytomegalovirus replication

  • Bioorg Med Chem. 1999 Jun;7(6):1067-74. doi: 10.1016/s0968-0896(99)00032-2.
M J Slater 1 S Cockerill R Baxter R W Bonser K Gohil C Gowrie J E Robinson E Littler N Parry R Randall W Snowden
Affiliations

Affiliation

  • 1 GlaxoWellcome Medicines Research Centre, Stevenage, UK. MJS40312@glaxowellcome.co.uk
Abstract

In our search for new, safer anti-HCMV agents, we discovered that the natural product Arcyriaflavin A (la) was a potent inhibitor of HCMV replication in Cell Culture. A series of analogues (symmetrical indolocarbazoles) was synthesised to investigate structure activity relationships in this series against a range of herpes viruses (HCMV, VZV, HSV1, and 2). This identified a number of novel, selective and potent inhibitors of HCMV, 12,13-dihydro-2,10-difluoro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol e-5,7-(6H)-dione (1d) being the best example (IC50=40 nM, therapeutic index > 1450). Compounds described in this series were generally poor inhibitors of protein kinase C betaII, and no correlation was found between the ability to inhibit HCMV and the Enzyme PKC.

Figures
Products